2024-02-012025-01-312025-01-31false09314096NEURO-LINK EUROPE LTD.2025-10-3182990falseiso4217:GBPxbrli:pure093140962024-01-31093140962025-01-31093140962024-02-012025-01-31093140962023-01-31093140962024-01-31093140962023-02-012024-01-3109314096bus:SmallEntities2024-02-012025-01-3109314096bus:AuditExempt-NoAccountantsReport2024-02-012025-01-3109314096bus:FullAccounts2024-02-012025-01-3109314096bus:PrivateLimitedCompanyLtd2024-02-012025-01-3109314096core:WithinOneYear2025-01-3109314096core:AfterOneYear2025-01-3109314096core:WithinOneYear2024-01-3109314096core:AfterOneYear2024-01-3109314096core:ShareCapital2025-01-3109314096core:SharePremium2025-01-3109314096core:RevaluationReserve2025-01-3109314096core:OtherReservesSubtotal2025-01-3109314096core:RetainedEarningsAccumulatedLosses2025-01-3109314096core:ShareCapital2024-01-3109314096core:SharePremium2024-01-3109314096core:RevaluationReserve2024-01-3109314096core:OtherReservesSubtotal2024-01-3109314096core:RetainedEarningsAccumulatedLosses2024-01-3109314096core:LandBuildings2025-01-3109314096core:PlantMachinery2025-01-3109314096core:Vehicles2025-01-3109314096core:FurnitureFittings2025-01-3109314096core:OfficeEquipment2025-01-3109314096core:NetGoodwill2025-01-3109314096core:IntangibleAssetsOtherThanGoodwill2025-01-3109314096core:ListedExchangeTraded2025-01-3109314096core:UnlistedNon-exchangeTraded2025-01-3109314096core:LandBuildings2024-01-3109314096core:PlantMachinery2024-01-3109314096core:Vehicles2024-01-3109314096core:FurnitureFittings2024-01-3109314096core:OfficeEquipment2024-01-3109314096core:NetGoodwill2024-01-3109314096core:IntangibleAssetsOtherThanGoodwill2024-01-3109314096core:ListedExchangeTraded2024-01-3109314096core:UnlistedNon-exchangeTraded2024-01-3109314096core:LandBuildings2024-02-012025-01-3109314096core:PlantMachinery2024-02-012025-01-3109314096core:Vehicles2024-02-012025-01-3109314096core:FurnitureFittings2024-02-012025-01-3109314096core:OfficeEquipment2024-02-012025-01-3109314096core:NetGoodwill2024-02-012025-01-3109314096core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3109314096core:ListedExchangeTraded2024-02-012025-01-3109314096core:UnlistedNon-exchangeTraded2024-02-012025-01-3109314096core:MoreThanFiveYears2024-02-012025-01-3109314096core:Non-currentFinancialInstruments2025-01-3109314096core:Non-currentFinancialInstruments2024-01-3109314096dpl:CostSales2024-02-012025-01-3109314096dpl:DistributionCosts2024-02-012025-01-3109314096core:LandBuildings2024-02-012025-01-3109314096core:PlantMachinery2024-02-012025-01-3109314096core:Vehicles2024-02-012025-01-3109314096core:FurnitureFittings2024-02-012025-01-3109314096core:OfficeEquipment2024-02-012025-01-3109314096dpl:AdministrativeExpenses2024-02-012025-01-3109314096core:NetGoodwill2024-02-012025-01-3109314096core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3109314096dpl:GroupUndertakings2024-02-012025-01-3109314096dpl:ParticipatingInterests2024-02-012025-01-3109314096dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-012025-01-3109314096core:ListedExchangeTraded2024-02-012025-01-3109314096dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-012025-01-3109314096core:UnlistedNon-exchangeTraded2024-02-012025-01-3109314096dpl:CostSales2023-02-012024-01-3109314096dpl:DistributionCosts2023-02-012024-01-3109314096core:LandBuildings2023-02-012024-01-3109314096core:PlantMachinery2023-02-012024-01-3109314096core:Vehicles2023-02-012024-01-3109314096core:FurnitureFittings2023-02-012024-01-3109314096core:OfficeEquipment2023-02-012024-01-3109314096dpl:AdministrativeExpenses2023-02-012024-01-3109314096core:NetGoodwill2023-02-012024-01-3109314096core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3109314096dpl:GroupUndertakings2023-02-012024-01-3109314096dpl:ParticipatingInterests2023-02-012024-01-3109314096dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012024-01-3109314096core:ListedExchangeTraded2023-02-012024-01-3109314096dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012024-01-3109314096core:UnlistedNon-exchangeTraded2023-02-012024-01-3109314096core:NetGoodwill2025-01-3109314096core:IntangibleAssetsOtherThanGoodwill2025-01-3109314096core:LandBuildings2025-01-3109314096core:PlantMachinery2025-01-3109314096core:Vehicles2025-01-3109314096core:FurnitureFittings2025-01-3109314096core:OfficeEquipment2025-01-3109314096core:AfterOneYear2025-01-3109314096core:WithinOneYear2025-01-3109314096core:ListedExchangeTraded2025-01-3109314096core:UnlistedNon-exchangeTraded2025-01-3109314096core:ShareCapital2025-01-3109314096core:SharePremium2025-01-3109314096core:RevaluationReserve2025-01-3109314096core:OtherReservesSubtotal2025-01-3109314096core:RetainedEarningsAccumulatedLosses2025-01-3109314096core:NetGoodwill2024-01-3109314096core:IntangibleAssetsOtherThanGoodwill2024-01-3109314096core:LandBuildings2024-01-3109314096core:PlantMachinery2024-01-3109314096core:Vehicles2024-01-3109314096core:FurnitureFittings2024-01-3109314096core:OfficeEquipment2024-01-3109314096core:AfterOneYear2024-01-3109314096core:WithinOneYear2024-01-3109314096core:ListedExchangeTraded2024-01-3109314096core:UnlistedNon-exchangeTraded2024-01-3109314096core:ShareCapital2024-01-3109314096core:SharePremium2024-01-3109314096core:RevaluationReserve2024-01-3109314096core:OtherReservesSubtotal2024-01-3109314096core:RetainedEarningsAccumulatedLosses2024-01-3109314096core:NetGoodwill2023-01-3109314096core:IntangibleAssetsOtherThanGoodwill2023-01-3109314096core:LandBuildings2023-01-3109314096core:PlantMachinery2023-01-3109314096core:Vehicles2023-01-3109314096core:FurnitureFittings2023-01-3109314096core:OfficeEquipment2023-01-3109314096core:AfterOneYear2023-01-3109314096core:WithinOneYear2023-01-3109314096core:ListedExchangeTraded2023-01-3109314096core:UnlistedNon-exchangeTraded2023-01-3109314096core:ShareCapital2023-01-3109314096core:SharePremium2023-01-3109314096core:RevaluationReserve2023-01-3109314096core:OtherReservesSubtotal2023-01-3109314096core:RetainedEarningsAccumulatedLosses2023-01-3109314096core:AfterOneYear2024-02-012025-01-3109314096core:WithinOneYear2024-02-012025-01-3109314096core:Non-currentFinancialInstrumentscore:CostValuation2024-02-012025-01-3109314096core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-012025-01-3109314096core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-012025-01-3109314096core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-012025-01-3109314096core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-012025-01-3109314096core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-012025-01-3109314096core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3109314096core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3109314096core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3109314096core:Non-currentFinancialInstrumentscore:CostValuation2025-01-3109314096core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-3109314096core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-3109314096core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-3109314096core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-3109314096core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-3109314096core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-3109314096core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-3109314096core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-3109314096core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3109314096core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3109314096core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3109314096core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3109314096core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3109314096core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3109314096core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3109314096core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3109314096core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3109314096bus:Director12024-02-012025-01-3109314096bus:Director22024-02-012025-01-31

NEURO-LINK EUROPE LTD.

Registered Number
09314096
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2025

NEURO-LINK EUROPE LTD.
Company Information
for the year from 1 February 2024 to 31 January 2025

Directors

VERMEULEN, Andre, Dr
VERMEULEN, Christiaan Louis

Registered Address

Whiteleaf Business Centre
11 Little Balmer
Buckingham
MK18 1TF

Registered Number

09314096 (England and Wales)
NEURO-LINK EUROPE LTD.
Balance Sheet as at
31 January 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets33,3953,868
3,3953,868
Current assets
Debtors4,7596,938
Cash at bank and on hand5,86818,635
10,62725,573
Creditors amounts falling due within one year4(383)(485)
Net current assets (liabilities)10,24425,088
Total assets less current liabilities13,63928,956
Net assets13,63928,956
Capital and reserves
Called up share capital100100
Profit and loss account13,53928,856
Shareholders' funds13,63928,956
The financial statements were approved and authorised for issue by the Board of Directors on 31 October 2025, and are signed on its behalf by:
VERMEULEN, Christiaan Louis
Director
Registered Company No. 09314096
NEURO-LINK EUROPE LTD.
Notes to the Financial Statements
for the year ended 31 January 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation. Amortisation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases: Other intangibles - 10% straight line
2.Average number of employees

20252024
Average number of employees during the year22
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 February 244,7364,736
At 31 January 254,7364,736
Amortisation and impairment
At 01 February 24868868
Charge for year473473
At 31 January 251,3411,341
Net book value
At 31 January 253,3953,395
At 31 January 243,8683,868
4.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables317317
Taxation and social security66168
Total383485
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.